Nisa Netinatsunton
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Nisa Netinatsunton has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Bancha Ovartlarnporn
Nanthana-Kriangkrai Chotiwattanaphan (NKC) Institute of Gastroenterology and Hepatology, Faculty of Medicine, Prince of Songkla University, Hat Yai 90110, Thailand
6 shared publications - Tanawat Pattarapuntakul
Gastroenterology and Hepatology Unit, Division of Internal Medicine, Faculty of Medicine, Prince of Songkla University, Hat Yai, Thailand
6 shared publications - Thanawin Wong
Nanthana-Kriangkrai Chotiwattanaphan (NKC) Institute of Gastroenterology and Hepatology, Faculty of Medicine, Prince of Songkla University, Hat Yai 90110, Thailand
6 shared publications - Pimsiri Sripongpun
Gastroenterology and Hepatology Unit, Division of Internal Medicine, Faculty of Medicine, Prince of Songkla University, Hat Yai 90110, Songkhla, Thailand
5 shared publications - Jaksin Sottisuporn
Nanthana-Kriangkrai Chotiwattanaphan (NKC) Institute of Gastroenterology and Hepatology, Faculty of Medicine, Prince of Songkla University, Hat Yai 90110, Thailand
4 shared publications - Naichaya Chamroonkul
Gastroenterology and Hepatology Unit, Division of Internal Medicine, Faculty of Medicine, Prince of Songkla University, Hat Yai, Thailand
3 shared publications
Latest Publications
- Open Access
- 17 November 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (22) , 3820
Diagnostic Yield of Endocuff-Assisted Colonoscopy with Double Right-Sided Examination on Adenoma Miss Rate and Detection Rate: A Randomized Controlled Trial
Objectives: Right-sided colonic polyps are frequently missed during standard colonoscopy (SC). While double right-sided colon examinations reduce the right-sided adenoma miss rate (rAMR), Endocuff-assisted colonoscopy (EAC) enhances mechanical fold-flattening to improve visualization. This trial aimed to evaluate the additive diagnostic efficacy and safety of EAC versus SC, both performed with a mandatory double right-sided examination. Methods: Patients undergoing elective colonoscopy were prospectively randomized (1:1) to either the EAC or SC group. A mandatory second examination of the right colon was performed in both cohorts. Primary outcome was overall adenoma detection rate (ADR). Secondary outcomes included rAMR, serrated lesion detection rate (SDR), procedural metrics, and adverse events. Results: A total of 354 patients (268 females; median age: 55 years) were analyzed (177 per group). Overall cohort ADR was 30.8%. EAC showed no statistically significant difference compared with SC regarding ADR (29.4% [52/177] vs. 32.2% [57/177]; absolute difference: −2.8%; 95% CI: −12.4% to 6.8%; p = 0.645) or rAMR (15.0% [3/20] vs. 5.9% [1/17]; absolute difference: +9.1%; 95% CI: −10.1% to 28.4%; p = 0.610). While EAC retrieved significantly more total polyps (178 vs. 138; p = 0.010), this was driven predominantly by diminutive lesions (p = 0.131). Minor mucosal lacerations were numerically higher in EAC (17.5% [31/177] vs. 10.7% [19/177]; absolute difference: +6.8%; 95% CI: −0.4% to 14.0%; p = 0.081), with no major complications in either group. Conclusions: Within the framework of a mandatory double right-sided examination, EAC demonstrated diagnostic performance comparable to standard colonoscopy for overall ADR, rAMR, and SDR. While EAC enhanced the detection yield of diminutive polyps, its incremental patient-level benefit should be weighed against potential histopathology costs. The observed trends suggest EAC remains a valuable tool for optimizing mucosal exposure, though larger studies are warranted to fully define its clinical role.
- 17 November 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (22) , 3820
Open AccessDiagnostic Yield of Endocuff-Assisted Colonoscopy with Double Right-Sided Examination on Adenoma Miss Rate and Detection Rate: A Randomized Controlled Trial
Objectives: Right-sided colonic polyps are frequently missed during standard colonoscopy (SC). While double right-sided colon examinations reduce the right-sided adenoma miss rate (rAMR), Endocuff-assisted colonoscopy (EAC) enhances mechanical fold-flattening to improve visualization. This trial aimed to evaluate the additive diagnostic efficacy and safety of EAC versus SC, both performed with a mandatory double right-sided examination. Methods: Patients undergoing elective colonoscopy were prospectively randomized (1:1) to either the EAC or SC group. A mandatory second examination of the right colon was performed in both cohorts. Primary outcome was overall adenoma detection rate (ADR). Secondary outcomes included rAMR, serrated lesion detection rate (SDR), procedural metrics, and adverse events. Results: A total of 354 patients (268 females; median age: 55 years) were analyzed (177 per group). Overall cohort ADR was 30.8%. EAC showed no statistically significant difference compared with SC regarding ADR (29.4% [52/177] vs. 32.2% [57/177]; absolute difference: −2.8%; 95% CI: −12.4% to 6.8%; p = 0.645) or rAMR (15.0% [3/20] vs. 5.9% [1/17]; absolute difference: +9.1%; 95% CI: −10.1% to 28.4%; p = 0.610). While EAC retrieved significantly more total polyps (178 vs. 138; p = 0.010), this was driven predominantly by diminutive lesions (p = 0.131). Minor mucosal lacerations were numerically higher in EAC (17.5% [31/177] vs. 10.7% [19/177]; absolute difference: +6.8%; 95% CI: −0.4% to 14.0%; p = 0.081), with no major complications in either group. Conclusions: Within the framework of a mandatory double right-sided examination, EAC demonstrated diagnostic performance comparable to standard colonoscopy for overall ADR, rAMR, and SDR. While EAC enhanced the detection yield of diminutive polyps, its incremental patient-level benefit should be weighed against potential histopathology costs. The observed trends suggest EAC remains a valuable tool for optimizing mucosal exposure, though larger studies are warranted to fully define its clinical role.
- Open Access
- 28 February 2025
- Published by Faculty of Medicine Prince of Songkla University in Journal of Health Science and Medical Research
- p. 20251160
Endoscopic Ultrasound-Guided Biliary Drainage Versus Ercp in Inoperable Malignant High-Grade Distal Bile Duct Obstruction: A Randomized Study; Preliminary Analysis
Objective: To compare the efficacy and safety of Endoscopic ultrasound-guided choledochoduodenostomy (EUS-CDS) and Endoscopic retrograde cholangiopancreatography (ERCP) for biliary drainage of high-grade malignant distal bile duct obstruction (HGMDBO).Material and Methods: Patients with inoperable HGMDBO were randomized to undergo either: EUS-CDS or ERCP. HGMDBO was defined as total bilirubin ≥15 mg/dl and/or a common bile duct size ≥12 mm. The other procedure was performed if the utilized surgery failed: success rates, procedure time and complication rates were assessed.Results: Preliminary analysis included 10 patients (5 per group); from August 2018 to January 2019, whose demographic data were similar. Technical success rates were at 60% (3/5) vs. 80% (4/5) for EUS-CDS and ERCP, respectively. Clinical success rates were at 80% (4/5) for both. The mean (S.D.) procedure times were 33.72 (14.5) and 45.22 (26.74) min for EUS-CDS and ERCP, respectively, without any significant difference (p-value=0.498). Adverse events in the EUS-CDS group included one case of mild biliary peritonitis and one case of post-sphincterotomy bleeding, while the ERCP group included one case of cholangitis with liver abscess and one case of mild bleeding.Conclusion: Preliminary data showed similar technical and clinical success rates. EUS-CDS had a shorter mean procedure time than that of ERCP; however, statistical significance was not reached. Further comprehensive studies are needed to validate the role of EUS-CDS as a primary drainage procedure.
- 28 February 2025
- Published by Faculty of Medicine Prince of Songkla University in Journal of Health Science and Medical Research
- p. 20251160
Open AccessEndoscopic Ultrasound-Guided Biliary Drainage Versus Ercp in Inoperable Malignant High-Grade Distal Bile Duct Obstruction: A Randomized Study; Preliminary Analysis
Objective: To compare the efficacy and safety of Endoscopic ultrasound-guided choledochoduodenostomy (EUS-CDS) and Endoscopic retrograde cholangiopancreatography (ERCP) for biliary drainage of high-grade malignant distal bile duct obstruction (HGMDBO).Material and Methods: Patients with inoperable HGMDBO were randomized to undergo either: EUS-CDS or ERCP. HGMDBO was defined as total bilirubin ≥15 mg/dl and/or a common bile duct size ≥12 mm. The other procedure was performed if the utilized surgery failed: success rates, procedure time and complication rates were assessed.Results: Preliminary analysis included 10 patients (5 per group); from August 2018 to January 2019, whose demographic data were similar. Technical success rates were at 60% (3/5) vs. 80% (4/5) for EUS-CDS and ERCP, respectively. Clinical success rates were at 80% (4/5) for both. The mean (S.D.) procedure times were 33.72 (14.5) and 45.22 (26.74) min for EUS-CDS and ERCP, respectively, without any significant difference (p-value=0.498). Adverse events in the EUS-CDS group included one case of mild biliary peritonitis and one case of post-sphincterotomy bleeding, while the ERCP group included one case of cholangitis with liver abscess and one case of mild bleeding.Conclusion: Preliminary data showed similar technical and clinical success rates. EUS-CDS had a shorter mean procedure time than that of ERCP; however, statistical significance was not reached. Further comprehensive studies are needed to validate the role of EUS-CDS as a primary drainage procedure.
- Open Access
- 20 June 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (12) , 3606
Efficacy of Vonoprazan vs. Intravenous Proton Pump Inhibitor in Prevention of Re-Bleeding of High-Risk Peptic Ulcers: A Randomized Controlled Pilot Study
Background: Proton pump inhibitor (PPI) therapy is well-established for its effectiveness in reducing re-bleeding in high-risk peptic ulcer patients following endoscopic hemostasis. Vonoprazan (VPZ) has demonstrated the capacity to achieve gastric pH levels exceeding 4, comparable to PPIs. This study aims to evaluate the comparative efficacy of intravenous PPI infusion versus VPZ in preventing re-bleeding after endoscopic hemostasis in patients with high-risk peptic ulcers. Methods: A randomized, double-blind, controlled, and double-dummy design was employed. Patients with peptic ulcer bleeding (Forrest class IA/IB or IIA/IIB) who underwent endoscopic hemostasis were randomly assigned to either the PPI group or the VPZ group. Re-bleeding rates at 3, 7, and 30 days, the number of blood transfusions required, length of hospitalization, and ulcer healing rate at 56 days were assessed. Results: A total of 44 eligible patients were enrolled, including 20 patients (PPI group, n = 11; VPZ group, n = 9) with high-risk peptic ulcers. The mean age was 66 years, with 70% being male. Re-bleeding within 72 h occurred in 9.1% of the PPI group versus 0% in the VPZ group (p = 1.000). There was no significant difference in re-bleeding rates within 7 days and 30 days (18.2% vs. 11.1%, p = 1.000). Additionally, the ulcer healing rate did not significantly differ between the groups (87.5% vs. 77.8%). Conclusions: This pilot study demonstrates comparable efficacy between oral vonoprazan and continuous PPI infusion in preventing recurrent bleeding events among high-risk peptic ulcer patients following successful endoscopic hemostasis.
- 20 June 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (12) , 3606
Open AccessEfficacy of Vonoprazan vs. Intravenous Proton Pump Inhibitor in Prevention of Re-Bleeding of High-Risk Peptic Ulcers: A Randomized Controlled Pilot Study
Background: Proton pump inhibitor (PPI) therapy is well-established for its effectiveness in reducing re-bleeding in high-risk peptic ulcer patients following endoscopic hemostasis. Vonoprazan (VPZ) has demonstrated the capacity to achieve gastric pH levels exceeding 4, comparable to PPIs. This study aims to evaluate the comparative efficacy of intravenous PPI infusion versus VPZ in preventing re-bleeding after endoscopic hemostasis in patients with high-risk peptic ulcers. Methods: A randomized, double-blind, controlled, and double-dummy design was employed. Patients with peptic ulcer bleeding (Forrest class IA/IB or IIA/IIB) who underwent endoscopic hemostasis were randomly assigned to either the PPI group or the VPZ group. Re-bleeding rates at 3, 7, and 30 days, the number of blood transfusions required, length of hospitalization, and ulcer healing rate at 56 days were assessed. Results: A total of 44 eligible patients were enrolled, including 20 patients (PPI group, n = 11; VPZ group, n = 9) with high-risk peptic ulcers. The mean age was 66 years, with 70% being male. Re-bleeding within 72 h occurred in 9.1% of the PPI group versus 0% in the VPZ group (p = 1.000). There was no significant difference in re-bleeding rates within 7 days and 30 days (18.2% vs. 11.1%, p = 1.000). Additionally, the ulcer healing rate did not significantly differ between the groups (87.5% vs. 77.8%). Conclusions: This pilot study demonstrates comparable efficacy between oral vonoprazan and continuous PPI infusion in preventing recurrent bleeding events among high-risk peptic ulcer patients following successful endoscopic hemostasis.
- Open Access
- 12 January 2024
- Published by MDPI AG in Diagnostics
- Vol. 14 (2) , 172
Predictive Factors Correlated with Successful Early Endoscopic Removal of Pancreaticolithiasis in Chronic Pancreatitis after Extracorporeal Shock Wave Lithotripsy
Background: The treatment of chronic pancreatitis (CP) and symptomatic pancreatic duct (PD) calculi often involves techniques like endoscopic retrograde cholangiopancreatography (ERCP), extracorporeal shock wave lithotripsy (ESWL), or a combination of both. However, identifying predictive factors for the successful removal of these calculi remains variable. This study aimed to determine the factors predicting successful ESWL and endoscopic removal in CP and PD calculi patients. Methods: We examined data from CP patients who underwent complete PD calculi removal via ESWL combined with ERCP between July 2012 and 2022, and assessed baseline characteristics, imaging findings, and treatment details. Patients were categorized into early- and late-endoscopic complete removal groups (EER and LER groups, respectively). Results: Of the 27 patients analyzed, 74.1% were male with an average age of 44 ± 9.6 years. EER was achieved in 74% of the patients. Patients in the EER group exhibited smaller PD calculi diameter (8.5 vs. 19 mm, p = 0.012) and lower calculus density (964.6 vs. 1313.3 HU, p = 0.041) compared to the LER group. Notably, PD stricture and the rate of PD stent insertion were not different between the groups. A calculus density threshold of 1300 HU on non-contrast CT demonstrated 71% sensitivity and 80% specificity in predicting EER. Conclusions: Smaller and low-density PD calculi may serve as predictors for successful EER, potentially aiding in the management of CP patients with PD calculi.
- 12 January 2024
- Published by MDPI AG in Diagnostics
- Vol. 14 (2) , 172
Open AccessPredictive Factors Correlated with Successful Early Endoscopic Removal of Pancreaticolithiasis in Chronic Pancreatitis after Extracorporeal Shock Wave Lithotripsy
Background: The treatment of chronic pancreatitis (CP) and symptomatic pancreatic duct (PD) calculi often involves techniques like endoscopic retrograde cholangiopancreatography (ERCP), extracorporeal shock wave lithotripsy (ESWL), or a combination of both. However, identifying predictive factors for the successful removal of these calculi remains variable. This study aimed to determine the factors predicting successful ESWL and endoscopic removal in CP and PD calculi patients. Methods: We examined data from CP patients who underwent complete PD calculi removal via ESWL combined with ERCP between July 2012 and 2022, and assessed baseline characteristics, imaging findings, and treatment details. Patients were categorized into early- and late-endoscopic complete removal groups (EER and LER groups, respectively). Results: Of the 27 patients analyzed, 74.1% were male with an average age of 44 ± 9.6 years. EER was achieved in 74% of the patients. Patients in the EER group exhibited smaller PD calculi diameter (8.5 vs. 19 mm, p = 0.012) and lower calculus density (964.6 vs. 1313.3 HU, p = 0.041) compared to the LER group. Notably, PD stricture and the rate of PD stent insertion were not different between the groups. A calculus density threshold of 1300 HU on non-contrast CT demonstrated 71% sensitivity and 80% specificity in predicting EER. Conclusions: Smaller and low-density PD calculi may serve as predictors for successful EER, potentially aiding in the management of CP patients with PD calculi.
- Open Access
Clinical Outcomes of the Endoscopic Step-Up Approach with or without Radiology-Guided Percutaneous Drainage for Symptomatic Walled-Off Pancreatic Necrosis
Background and objectives: Symptomatic walled-off pancreatic necrosis is a serious local complication of acute necrotising pancreatitis. The endoscopic step-up approach is the standard treatment for symptomatic walled-off pancreatic necrosis; however, adjunctive radiologic percutaneous drainage for this condition is controversial. This study compared the clinical and radiologic resolution of walled-off pancreatic necrosis achieved with the endoscopic step-up approach with or without radiology-guided percutaneous drainage. Material and Methods: This retrospective, single-centre cohort study enrolled patients with symptomatic walled-off pancreatic necrosis who underwent endoscopic transmural drainage (ETD) followed by directed endoscopic necrosectomy (DEN) with or without radiology-guided drainage. A total of 34 patients (endoscopic approach, n = 22; combined modality approach, n = 12) underwent the endoscopic step-up approach (ETD followed by DEN). Baseline characteristics, clinical success, and resolution of necrosis were compared between groups. Results: All patients achieved symptom resolution from walled-off pancreatic necrosis. The mean patient age was 58.4 years, and 21 (61.8%) were men. Following treatment with the endoscopic approach and combined modality approach, clinical success was achieved in 90.9% of patients within 11.5 days, and 66.7% of patients within 16.5 days, respectively. Both length of hospital stay (55 days vs. 71 days; p = 0.071) and time to complete radiologic resolution were shorter (93 days vs. 124 days; p = 0.23) in the endoscopic approach group. Conclusion: Both the endoscopic step-up approach and the CMD approach resulted in a favourably high clinical resolution rates in patients with symptomatic WON. However, clinical success rates seemed to be higher, and the length of hospital stay tended to be shorter in the endoscopic approach than in the CMD approach, as well as the significantly shorter necrosectomy time in each procedure was observed. Of note, these findings might be from some inherited differences in baseline characteristics of the patients between the two groups, and a randomized controlled trial with a larger sample size to verify these results is warranted.
Open AccessClinical Outcomes of the Endoscopic Step-Up Approach with or without Radiology-Guided Percutaneous Drainage for Symptomatic Walled-Off Pancreatic Necrosis
Background and objectives: Symptomatic walled-off pancreatic necrosis is a serious local complication of acute necrotising pancreatitis. The endoscopic step-up approach is the standard treatment for symptomatic walled-off pancreatic necrosis; however, adjunctive radiologic percutaneous drainage for this condition is controversial. This study compared the clinical and radiologic resolution of walled-off pancreatic necrosis achieved with the endoscopic step-up approach with or without radiology-guided percutaneous drainage. Material and Methods: This retrospective, single-centre cohort study enrolled patients with symptomatic walled-off pancreatic necrosis who underwent endoscopic transmural drainage (ETD) followed by directed endoscopic necrosectomy (DEN) with or without radiology-guided drainage. A total of 34 patients (endoscopic approach, n = 22; combined modality approach, n = 12) underwent the endoscopic step-up approach (ETD followed by DEN). Baseline characteristics, clinical success, and resolution of necrosis were compared between groups. Results: All patients achieved symptom resolution from walled-off pancreatic necrosis. The mean patient age was 58.4 years, and 21 (61.8%) were men. Following treatment with the endoscopic approach and combined modality approach, clinical success was achieved in 90.9% of patients within 11.5 days, and 66.7% of patients within 16.5 days, respectively. Both length of hospital stay (55 days vs. 71 days; p = 0.071) and time to complete radiologic resolution were shorter (93 days vs. 124 days; p = 0.23) in the endoscopic approach group. Conclusion: Both the endoscopic step-up approach and the CMD approach resulted in a favourably high clinical resolution rates in patients with symptomatic WON. However, clinical success rates seemed to be higher, and the length of hospital stay tended to be shorter in the endoscopic approach than in the CMD approach, as well as the significantly shorter necrosectomy time in each procedure was observed. Of note, these findings might be from some inherited differences in baseline characteristics of the patients between the two groups, and a randomized controlled trial with a larger sample size to verify these results is warranted.
- Open Access
- 31 January 2023
- Published by MDPI AG in Preprints.org
Clinical Outcomes of the Endoscopic Step-Up Approach With or Without Radiology-Guided Percutaneous Drainage for Symptomatic Walled-Off Pancreatic Necrosis
Background and objectives: Symptomatic walled-off pancreatic necrosis is a serious local complication of acute necrotising pancreatitis. The endoscopic step-up approach is the standard treatment for symptomatic walled-off pancreatic necrosis; however, adjunctive radiologic percu-taneous drainage for this condition is controversial. This study compared the clinical and radio-logic resolution of walled-off pancreatic necrosis achieved with the endoscopic step-up approach with or without radiology-guided percutaneous drainage. Material and Methods: This retrospective, single-center cohort study enrolled patients with symp-tomatic walled-off pancreatic necrosis who underwent endoscopic transmural drainage (ETD) followed by directed endoscopic necrosectomy (DEN) with or without radiology-guided drainage. A total of 34 patients (endoscopic approach, n=22; combined modality approach, n=12) underwent the endoscopic step-up approach (ETD followed by DEN). Baseline characteristics, clinical success, and resolution of necrosis were compared between groups. Results: All patients achieved symptom resolution from walled-off pancreatic necrosis. The mean patient age was 58.4 years, and 21 (61.8%) were men. After treatment with the endoscopic approach and combined modality approach, clinical success was achieved in 90.9% of patients within 11.5 days, and 66.7% of patients within 16.5 days, respectively. Both the total hospital stay (55 days vs 71 days; p=0.071) and time to complete radiologic resolution were shorter (93 days vs 124 days; p=0.23) in the endoscopic approach group. Conclusion: The endoscopic step-up approach resulted in the clinical resolution of symptomatic walled-off pancreatic necrosis comparable to that of the combined modality drainage. However, the endoscopic approach alone allows higher clinical success, early clinical and radiologic resolution, and a shorter hospital stay.
- 31 January 2023
- Published by MDPI AG in Preprints.org
Open AccessClinical Outcomes of the Endoscopic Step-Up Approach With or Without Radiology-Guided Percutaneous Drainage for Symptomatic Walled-Off Pancreatic Necrosis
Background and objectives: Symptomatic walled-off pancreatic necrosis is a serious local complication of acute necrotising pancreatitis. The endoscopic step-up approach is the standard treatment for symptomatic walled-off pancreatic necrosis; however, adjunctive radiologic percu-taneous drainage for this condition is controversial. This study compared the clinical and radio-logic resolution of walled-off pancreatic necrosis achieved with the endoscopic step-up approach with or without radiology-guided percutaneous drainage. Material and Methods: This retrospective, single-center cohort study enrolled patients with symp-tomatic walled-off pancreatic necrosis who underwent endoscopic transmural drainage (ETD) followed by directed endoscopic necrosectomy (DEN) with or without radiology-guided drainage. A total of 34 patients (endoscopic approach, n=22; combined modality approach, n=12) underwent the endoscopic step-up approach (ETD followed by DEN). Baseline characteristics, clinical success, and resolution of necrosis were compared between groups. Results: All patients achieved symptom resolution from walled-off pancreatic necrosis. The mean patient age was 58.4 years, and 21 (61.8%) were men. After treatment with the endoscopic approach and combined modality approach, clinical success was achieved in 90.9% of patients within 11.5 days, and 66.7% of patients within 16.5 days, respectively. Both the total hospital stay (55 days vs 71 days; p=0.071) and time to complete radiologic resolution were shorter (93 days vs 124 days; p=0.23) in the endoscopic approach group. Conclusion: The endoscopic step-up approach resulted in the clinical resolution of symptomatic walled-off pancreatic necrosis comparable to that of the combined modality drainage. However, the endoscopic approach alone allows higher clinical success, early clinical and radiologic resolution, and a shorter hospital stay.
- Open Access
- 24 June 2022
- Published by Springer Nature in World Journal of Surgical Oncology
- Vol. 20 (1) , 1-8
Diagnostic performance of endoscopic ultrasound-guided tissue acquisition by EUS-FNA versus EUS-FNB for solid pancreatic mass without ROSE: a retrospective study
Background: Endoscopic ultrasound-guided tissue acquisition (EUS-TA) is an established diagnostic procedure for solid pancreatic mass. However, the diagnostic yield between fine-needle aspiration (FNA) and fine-needle biopsy (FNB) remains unclear. We aimed to evaluate and compare the diagnostic yields between FNA and FNB using conventional FNA and Franseen needles of the same size 22-gauge needle, in patients with solid pancreatic mass who underwent EUS-TA without rapid onsite cytopathology evaluation (ROSE). Methods: All cases of EUS-TA by FNA or FNB for solid pancreatic mass between January 2017 and October 2020 in a single-centre university hospital were retrospectively reviewed. All procedures were performed without an onsite cytologist. Before the endoscopist finished the procedure, macroscopic onsite evaluation (MOSE) was confirmed. The diagnostic yield and the average number of needle passes between FNB and FNA were then compared. Results: A total of 151 patients (FNA, n = 77; FNB, n = 74) with solid pancreatic mass detected by cross-sectional imaging underwent EUS-TA. The mean age was 62.3 ± 12.8 years, with 88 (58.3%) males. Age, sex, mass location, tumour size and disease stage from imaging were not significantly different between the two groups. The diagnostic performance was higher in EUS-FNB (94.6%) than in EUS-FNA (89.6%). The mean number of needle passes was clearly fewer in FNB than in FNA (2.8 vs. 3.8, p < 0.001). The total procedure time was shorter in FNB (34.7 min) than in FNA (41 min). The adverse event rate between FNB and FNA was not significantly different. Conclusions: The diagnostic yield of solid pancreatic mass was higher in FNB using the Franseen needle than in FNA using the conventional FNA needle in a centre where ROSE is unavailable, without serious adverse event. In addition, FNB had fewer needle passes and shorter total procedure time.
- 24 June 2022
- Published by Springer Nature in World Journal of Surgical Oncology
- Vol. 20 (1) , 1-8
Open AccessDiagnostic performance of endoscopic ultrasound-guided tissue acquisition by EUS-FNA versus EUS-FNB for solid pancreatic mass without ROSE: a retrospective study
Background: Endoscopic ultrasound-guided tissue acquisition (EUS-TA) is an established diagnostic procedure for solid pancreatic mass. However, the diagnostic yield between fine-needle aspiration (FNA) and fine-needle biopsy (FNB) remains unclear. We aimed to evaluate and compare the diagnostic yields between FNA and FNB using conventional FNA and Franseen needles of the same size 22-gauge needle, in patients with solid pancreatic mass who underwent EUS-TA without rapid onsite cytopathology evaluation (ROSE). Methods: All cases of EUS-TA by FNA or FNB for solid pancreatic mass between January 2017 and October 2020 in a single-centre university hospital were retrospectively reviewed. All procedures were performed without an onsite cytologist. Before the endoscopist finished the procedure, macroscopic onsite evaluation (MOSE) was confirmed. The diagnostic yield and the average number of needle passes between FNB and FNA were then compared. Results: A total of 151 patients (FNA, n = 77; FNB, n = 74) with solid pancreatic mass detected by cross-sectional imaging underwent EUS-TA. The mean age was 62.3 ± 12.8 years, with 88 (58.3%) males. Age, sex, mass location, tumour size and disease stage from imaging were not significantly different between the two groups. The diagnostic performance was higher in EUS-FNB (94.6%) than in EUS-FNA (89.6%). The mean number of needle passes was clearly fewer in FNB than in FNA (2.8 vs. 3.8, p < 0.001). The total procedure time was shorter in FNB (34.7 min) than in FNA (41 min). The adverse event rate between FNB and FNA was not significantly different. Conclusions: The diagnostic yield of solid pancreatic mass was higher in FNB using the Franseen needle than in FNA using the conventional FNA needle in a centre where ROSE is unavailable, without serious adverse event. In addition, FNB had fewer needle passes and shorter total procedure time.
- Open Access
- 14 January 2016
- Published by Springer Nature in BMC Gastroenterology
- Vol. 16 (1) , 1-8
i-Scan detection of minimal change esophagitis in dyspeptic patients with or without Gastroesophageal Reflux disease
The association of minimal change esophagitis (MCE) with GERD is controversial. i-Scan endoscopy (SE) provides high resolution and modulation of images that may improve minimal change lesion (MCL) detection. We aimed to assess the efficacy of SE in detecting MCL in dyspeptic patients with GERD compared with patients without GERD by GerdQ or by endoscopy with 24-h pH monitoring (PHM) and in normal volunteers. This is a cohort study conducted at a tertiary center. All dyspeptic patients were prospectively recruited. All patients completed a validated Thai version of GerdQ and then underwent endoscopy. Forty normal volunteers as a control group were recruited for endoscopy. The distal esophagus was examined by high definition endoscopy and SE sequentially. All had PHM done. GERD was diagnosed by Los Angeles classification A-D and/or by a positive PHM. MCE was diagnosed when MCL or combination of MCL was present. Of 174 patients, 144 completed the study protocol. After the exclusion of 6 patients, 138 remained for analysis. Overlapping GERD symptoms were found in 44.2 % and 26.8 % had confirmed GERD. Group A was comprised of 61 patients with a positive GerdQ and 77 patients in group B had a negative GerdQ. Twenty-four in group A, 28 in group B and 7 in the control group had MCE that was not significantly different. MCE in GERD was significantly higher (51.45 %) than in non-GERD (32.7 %) (p = 0.047) and in the control group (20.58 %) (p = 0.007). The sensitivity, specificity, positive predictive value, and negative predictive value of SE were 51.35 %, 67.33 %, 36.54 % and 79.06 %, respectively. In dyspeptic patients, SE detected more MCE in GERD than in non-GERD patients and in the control group. ClinicalTrials.gov number NCT01742377
- 14 January 2016
- Published by Springer Nature in BMC Gastroenterology
- Vol. 16 (1) , 1-8
Open Accessi-Scan detection of minimal change esophagitis in dyspeptic patients with or without Gastroesophageal Reflux disease
The association of minimal change esophagitis (MCE) with GERD is controversial. i-Scan endoscopy (SE) provides high resolution and modulation of images that may improve minimal change lesion (MCL) detection. We aimed to assess the efficacy of SE in detecting MCL in dyspeptic patients with GERD compared with patients without GERD by GerdQ or by endoscopy with 24-h pH monitoring (PHM) and in normal volunteers. This is a cohort study conducted at a tertiary center. All dyspeptic patients were prospectively recruited. All patients completed a validated Thai version of GerdQ and then underwent endoscopy. Forty normal volunteers as a control group were recruited for endoscopy. The distal esophagus was examined by high definition endoscopy and SE sequentially. All had PHM done. GERD was diagnosed by Los Angeles classification A-D and/or by a positive PHM. MCE was diagnosed when MCL or combination of MCL was present. Of 174 patients, 144 completed the study protocol. After the exclusion of 6 patients, 138 remained for analysis. Overlapping GERD symptoms were found in 44.2 % and 26.8 % had confirmed GERD. Group A was comprised of 61 patients with a positive GerdQ and 77 patients in group B had a negative GerdQ. Twenty-four in group A, 28 in group B and 7 in the control group had MCE that was not significantly different. MCE in GERD was significantly higher (51.45 %) than in non-GERD (32.7 %) (p = 0.047) and in the control group (20.58 %) (p = 0.007). The sensitivity, specificity, positive predictive value, and negative predictive value of SE were 51.35 %, 67.33 %, 36.54 % and 79.06 %, respectively. In dyspeptic patients, SE detected more MCE in GERD than in non-GERD patients and in the control group. ClinicalTrials.gov number NCT01742377